Showing results (2471-2480 of 3,087) with videos related to

Sort By:
Pageof 309
Drug Safety|August 24, 2022
Prescribing Patterns of Codeine and Alternative Medicines in Children in EuropeKelly Plueschke, Robert Flynn, Karin Hedenmalm, et al.
Drug Safety|August 7, 2022
Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social MediaSu Golder, Davy Weissenbacher, Karen O'Connor, et al.
Drug Safety|May 18, 2020
Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the NetherlandsLinda Härmark, Gerda Weits, Rietje Meijer, et al.
Drug Safety|April 11, 2020
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and ClarithromycinLorenzo Villa Zapata, Philip D Hansten, John R Horn, et al.
Drug Safety|August 2, 2021
NSAIDs and COVID-19: A Systematic Review and Meta-analysisNicholas Moore, Pauline Bosco-Levy, Nicolas Thurin, et al.
Drug Safety|May 21, 2015
PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trialsKristopher J Swiger, Seth S Martin
Drug Safety|May 27, 2020
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesJette A van Lint, Naomi T Jessurun, Renske C F Hebing, et al.
Drug Safety|June 6, 2020
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with IbuprofenRachel B Weinstein, Patrick B Ryan, Jesse A Berlin, et al.
Drug Safety|September 17, 2021
Drug-Induced Liver Injury: Highlights and Controversies in the Recent LiteratureJoseph William Clinton, Sara Kiparizoska, Soorya Aggarwal, et al.
Drug Safety|May 23, 2020
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World DataChristen M Gray, Fiona Grimson, Deborah Layton, et al.
Pageof 309